Finnegan Beats Humira IP Licensing Claims for AbbVie

A U.K. arthritis research trust overreached by demanding more patent royalties from drugmaker and longtime licensee AbbVie, an appeals court ruled on Thursday.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.